India faces a paradox at the intersection of medicine and drug law. On one hand, we have a severe unmet need for pain management — the WHO has repeatedly noted that India accounts for a disproportionately small share of the global consumption of opioid analgesics relative to its disease burden. On the other hand, the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) is one of the world's most stringent drug control laws, with criminal penalties that have historically made doctors afraid to prescribe necessary pain medications.

For a practising oncologist, palliative care specialist, or pain physician in India, the NDPS Act is not a peripheral concern — it is the primary legal framework that governs their ability to prescribe morphine, oxycodone, fentanyl, pethidine, and related drugs. Getting it wrong can mean criminal prosecution, not merely a Medical Council inquiry.

"The NDPS Act was designed to combat drug trafficking, but it created unintended barriers to legitimate medical use. Doctors in India have been prosecuted for prescribing morphine to dying cancer patients. Understanding exactly what the law requires — and what it does not prohibit — is essential for any doctor working in pain medicine or palliative care."
— Dr. Namit Gupta, Senior Medico-Legal Expert

The NDPS Act 1985: An Overview

The Narcotic Drugs and Psychotropic Substances Act, 1985, replaced the earlier Opium Act, Dangerous Drugs Act, and related legislation. It created a single comprehensive framework for the control of narcotic drugs and psychotropic substances. The Act classifies substances into schedules:

  • Schedule I: Narcotic drugs and psychotropic substances whose manufacture, possession, sale, and use are prohibited except for medical and scientific purposes under licence
  • Schedule II: Preparations of narcotic substances
  • Schedule III: Psychotropic substances (benzodiazepines, barbiturates, amphetamines, and others)
  • Schedule IV: Preparations of psychotropic substances

Opioids — morphine, codeine, oxycodone, fentanyl, pethidine, methadone, buprenorphine — are Schedule I narcotic drugs. Most benzodiazepines are Schedule III psychotropic substances. Possession, sale, or use of these substances outside the permitted framework is a criminal offence.

Which Drugs Require Special Prescription?

The following commonly used medical substances are controlled under the NDPS Act and require compliance with special prescribing rules:

Opioid Analgesics (Schedule I Narcotics)

  • Morphine (oral, injectable, sustained release)
  • Oxycodone
  • Fentanyl (patch, lozenge, injectable)
  • Hydromorphone
  • Pethidine (meperidine)
  • Methadone
  • Codeine (above a specified concentration)
  • Buprenorphine (used in opioid substitution therapy)
  • Tramadol (classified as a narcotic analgesic in many states)

Psychotropic Substances (Schedule III)

  • Diazepam
  • Nitrazepam
  • Flunitrazepam
  • Alprazolam (above specified concentrations)
  • Pentazocine
  • Methaqualone
  • Ketamine (in some state classifications)

Who Can Prescribe? The Licensing Requirement

The NDPS Act authorises "registered medical practitioners" to prescribe narcotic and psychotropic substances for legitimate medical purposes. However, the Act delegates substantial regulatory power to state governments, and this delegation has created a patchwork of state-specific rules.

In most Indian states, a doctor wishing to prescribe opioids for pain management must:

  • Hold a valid MBBS or equivalent degree and be registered with the State Medical Council
  • Obtain a narcotics licence or government registration from the State Drugs Controller, State Excise Department, or designated authority (varies by state)
  • Use the state-prescribed special prescription form (triplicate or otherwise) for each narcotic prescription
  • Maintain a register of all narcotic prescriptions issued

Without the state narcotics licence, even a senior oncologist at a major hospital technically cannot prescribe morphine for a terminal cancer patient in most Indian states — though informal arrangements at hospital level often substitute for individual doctor licences in large institutions.

The Triplicate Prescription System

Historically, many Indian states required narcotic prescriptions to be written on government-issued triplicate forms. These forms are sequentially numbered and provided to licensed doctors in controlled quantities. A prescription written on a triplicate form creates three copies:

  • White copy: Retained by the prescribing doctor
  • Yellow copy: Retained by the dispensing pharmacy
  • Pink copy: Submitted to the State Drugs Controller or Excise Department for audit

Not all states continue to use the full triplicate system — some have moved to computer-generated controlled prescriptions or other formats — but the principle of creating an auditable trail for every narcotic prescription is universal across India. Doctors should verify the currently prescribed format with their state drugs authority.

Permitted Quantities Per Prescription

The NDPS Rules (as amended in 2014) permit a registered medical practitioner to prescribe up to a 30-day supply of essential narcotic analgesics in a single prescription for patients with terminal illness or requiring long-term pain management. This was a significant reform — prior to 2014, many states limited prescriptions to 7 days, creating enormous burden on dying patients who had to obtain fresh prescriptions weekly.

However, the 30-day limit applies at the federal level; some states have more restrictive limits under their own narcotic drug rules. Always verify the state-specific limit before prescribing.

State Variation: The Kerala Model

Kerala is widely cited as India's best example of accessible narcotic prescribing for palliative care. In 1998, Kerala amended its own NDPS Rules to significantly simplify access to oral morphine. Under the Kerala model:

  • Any registered medical practitioner (not just licensed specialists) can prescribe oral morphine for palliative care
  • Prescriptions can be written on standard prescription pads (not special government forms)
  • Community health workers can transport morphine to patients at home
  • The result has been substantially better pain management outcomes for terminal patients in Kerala compared to other Indian states

Other states — notably Tamil Nadu, Karnataka, Maharashtra, and Himachal Pradesh — have partially adopted aspects of the Kerala model, but most of India continues to operate under restrictive frameworks that limit access to opioid analgesia.

Criminal Penalties Under the NDPS Act

The NDPS Act is not a regulatory statute with administrative penalties — it is a criminal law with serious imprisonment provisions:

  • Section 22: Contravention of provisions relating to psychotropic substances — up to 10 years rigorous imprisonment and a fine of up to Rs. 1 lakh (for small quantity); up to 20 years for commercial quantity
  • Section 18: Contravention relating to opium poppy and opium — up to 10 years or 20 years depending on quantity
  • Section 21: Contravention relating to manufactured drugs (including morphine) — up to 10 years or 20 years depending on quantity

Crucially, the NDPS Act creates a reverse burden of proof in many situations: once possession or use of a controlled substance is established, the accused must prove that it was for a legitimate medical purpose. This reversal of the normal criminal law presumption of innocence makes compliance with prescription formalities particularly important — a doctor's licence, triplicate prescription, and register entries are their evidence.

Safe Access to Essential Medicines: NMC and WHO Guidelines

The Medical Council of India (now NMC) has, in various advisories, urged doctors not to be deterred from prescribing essential narcotic analgesics for patients in genuine pain by an exaggerated fear of prosecution. The key point from these advisories is that a doctor who:

  • Holds the required state narcotics licence
  • Uses the required prescription format
  • Prescribes within the permitted quantity per prescription
  • Maintains the required prescription register
  • Has a documentable clinical basis for the prescription

...faces no criminal risk under the NDPS Act. The risk arises only from procedural non-compliance.

The WHO's model guidelines on ensuring access to essential medicines for pain management have also been incorporated into India's National Cancer Control Programme guidelines, which recognise adequate opioid availability as a component of the right to health.

Practical Checklist for Oncologists and Pain Physicians

  • Obtain your state narcotics licence — contact your State Drugs Controller or Excise Department; do not rely solely on hospital-level licences if you practise independently
  • Obtain the state-prescribed prescription forms (triplicate or other) from the licensing authority
  • Never prescribe on a standard Rx pad for Schedule I narcotics if your state requires special forms
  • Document the clinical indication clearly — stage of cancer, pain score, previous analgesic ladder steps tried
  • Maintain your narcotic prescription register meticulously — date, patient name, drug, quantity, prescriber signature
  • Do not exceed the maximum quantity permitted per prescription in your state
  • Counsel the patient and carer on storage, safe custody, and not sharing the medication
  • For outpatient palliative care, consider written communication to the dispensing pharmacy confirming the patient's diagnosis and the legitimacy of the prescription

Conclusion

The NDPS Act creates real criminal risk for doctors who prescribe narcotic and psychotropic drugs without complying with state-specific licence and prescription format requirements. But it does not — and should not — prevent doctors from managing pain appropriately in patients with cancer, chronic conditions, or terminal illness. The law provides a clear path to lawful prescribing: obtain the licence, use the correct form, document the clinical basis, and maintain the register.

If you are an oncologist, anaesthesiologist, or palliative care specialist with questions about NDPS compliance in your state, or if you have received a police or Excise Department notice relating to narcotic prescribing, contact our medico-legal team immediately for expert guidance.